High prevalence of oncogenic human papilloma virus in women not attending organized cytological screening

Acta Dermato-Venereologica

Volumn 87, Issue 3, 2007, Pages 243-245

  Stenvall, Harriet ^a   Wikström, Ingrid ^a   Wilander, Erik ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gynaecological screening; HPV test; Self sampling; Vagina

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CYTOLOGY; DEVICE; FEMALE; HIGH RISK POPULATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; METHODOLOGY; PAPILLOMA VIRUS; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VAGINA SMEAR; ATTITUDE TO HEALTH; ISOLATION AND PURIFICATION; MASS SCREENING; MIDDLE AGED; PATIENT ATTITUDE; SELF CARE; SWEDEN; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

VIRUS DNA;

ADULT; ATTITUDE TO HEALTH; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; SELF CARE; SWEDEN; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 34249050351     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0205     Document Type: Article

References (16)

1. Bergström R, Sparen P, Adami HO. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer 1999; 81: 159-166.
2. Sasieni PD, Cuzick J, Lynch-Farmery E. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group. Br J Cancer. 1996; 73: 1001-1005.
3. Stenkvist B, Söderstrom J. Reasons for cervical cancer despite extensive screening. J Med Screen. 1996; 3: 204-207.
4. Jansson Å, Gustafsson M, Wilander E. Efficiency of cytological screening for detection of cervical squamous carcinoma. Ups J Med Sci 1998; 103: 147-154.
5. Eaker S, Adami HO, Sparen P. Reasons women do not attend screening for cervical cancer: a population-based study in Sweden. Prev Med 2001; 32: 482-491.
6. Eaker S, Adami HO, Granath F, Wilander E, Sparen P. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 346-354.
7. Brink A, Snijders P, Meijer C, Berkhof J, Verheijen R. HPV testing in cervical screening. Best Practice & Research Clinical Obstetrics & Gynaecology 2006; 20: 253-266. Available from: http://www.sciencedirect.com
8. Stenvall H, Wikström I, Wilander E. HPV testing of vaginal smear obtained with a novel self-sampling device. Acta Derm Venereol 2006; 86: 465.
9. Digene Corporation: Hybrid Capture Technology HC2. Available from: http://www.digene.com.
10. Forslund O, Antonsson A, Edlund K, van den Brule AJ, Hansson BG, Meijer CJ, et al. Population-based type-specific prevalence of high-risk human papilloma virus infection in middle-aged Swedish women. J Med Virol 2002; 66: 535-541.
11. Harper DM, Hildesheim A, Cobb JL, Greenberg M, Vaught J, Lorincz AT. Collection devices for human papillomavirus. J Fam Pract 1999; 48: 531-535.
12. Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, et al. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 2000; 163: 513-518.
13. Gravitt PE, Lacey JV Jr, Brinton LA, Barnes WA, Kornegay JR, Greenberg M, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 2001; 10: 95-100.
14. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Jaspars LH, Voorhorst FJ, et al. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol 2002; 55: 435-439.
15. Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283: 81-86.
16. Bais AG, Rebolj M, Snijders PJ, de Schipper FA, van der Meulen DA, Verheijen RH, et al. Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelines. Int J Cancer 2005; 116: 122-129.